Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six research firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $13.00.
A number of analysts have recently issued reports on SENS shares. Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a report on Saturday, August 8th. Mizuho decreased their price objective on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Barclays assumed coverage on Senseonics Holdings, Inc. Common Stock in a report on Wednesday, October 7th. They issued an “equal weight” rating and a $10.00 price objective on the stock. TD Cowen reiterated a “buy” rating and issued a $15.00 price objective on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday. Finally, Weiss Ratings cut Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, October 22nd.
View Our Latest Report on Senseonics Holdings, Inc. Common Stock
Insider Activity at Senseonics Holdings, Inc. Common Stock
In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder purchased 13,953 shares of the stock in a transaction dated Wednesday, August 19th. The stock was acquired at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the acquisition, the director owned 171,191 shares in the company, valued at $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 4.70% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $15,867,000. Bank of America Corp DE acquired a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth $2,241,000. Masters Capital Management LLC boosted its position in shares of Senseonics Holdings, Inc. Common Stock by 100.0% during the first quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock worth $3,330,000 after buying an additional 250,002 shares during the period. Readystate Asset Management LP purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $574,000. Finally, Penn Capital Management Company LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at $535,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.
Senseonics Holdings, Inc. Common Stock Trading Down 2.5%
Shares of SENS stock opened at $9.51 on Monday. The company’s 50-day moving average price is $9.19 and its 200-day moving average price is $7.21. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62. The stock has a market cap of $397.55 million, a price-to-earnings ratio of -4.26 and a beta of 1.02. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $10.64.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The firm had revenue of $14.48 million during the quarter. As a group, equities analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current year.
Senseonics Holdings, Inc. Common Stock Company Profile
Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.
The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.
Further Reading
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
